Hikma 503B is an FDA-Registered outsourced sterile compounding business focused on providing high quality, ready-to-administer injectable medications that are customized to the specific needs of patients in the United States. Hikma 503B builds on the Hikma group’s expertise and position as a leading supplier of injectable medicines to US hospitals with a strong reputation for quality and reliability. Our goal is to provide our US hospital customers a reliable source of high quality compounded sterile preparations to enable them to meet the needs of their providers and patients.

Hikma 503B

Org chart

Teams

Offices